31600-56-3 Usage
Description
[(2-methoxyethoxy)methyl]benzene, also known by its IUPAC name 1-[(2-methoxyethoxy)methyl]benzene, is a chemical compound characterized by its molecular formula C10H14O3. This colorless liquid exhibits a faint and sweet odor, making it a versatile compound for various applications.
Uses
Used in the Paint and Coatings Industry:
[(2-methoxyethoxy)methyl]benzene is used as a solvent for enhancing the properties of paints, coatings, and adhesives. Its ability to dissolve a wide range of substances contributes to the improved performance and durability of these products.
Used in the Adhesives Industry:
In the adhesives industry, [(2-methoxyethoxy)methyl]benzene serves as a solvent that aids in the formulation of adhesives with specific bonding properties. Its use results in adhesives with better adhesion and resistance to various environmental conditions.
Used in the Synthesis of Specialty Chemicals:
[(2-methoxyethoxy)methyl]benzene is utilized as an intermediate in the synthesis of specialty chemicals. Its unique chemical structure allows for the creation of a variety of complex molecules with specific applications in different industries.
Used in the Pharmaceutical Industry:
Within the pharmaceutical sector, [(2-methoxyethoxy)methyl]benzene is employed in the synthesis of various drugs. Its role as a building block in the development of new medications highlights its importance in the healthcare field.
Safety and Environmental Considerations:
[(2-methoxyethoxy)methyl]benzene is considered to have low toxicity and is not expected to pose significant risks to human health or the environment when properly handled and used according to safety guidelines. However, it is crucial to handle this chemical with care and use appropriate personal protective equipment when working with it to minimize any potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 31600-56-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,6,0 and 0 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 31600-56:
(7*3)+(6*1)+(5*6)+(4*0)+(3*0)+(2*5)+(1*6)=73
73 % 10 = 3
So 31600-56-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H14O2/c1-11-7-8-12-9-10-5-3-2-4-6-10/h2-6H,7-9H2,1H3
31600-56-3Relevant articles and documents
Iridium solutes effect C-H bond activation and C-C bond forming reactions of C6H6-MeOCH2CH2OMe solvent mixtures
Paneque, Margarita,Poveda, Manuel L.,Santos, Laura L.,Salazar, Veronica,Carmona, Ernesto
, p. 1838 - 1839 (2004)
The in situ generated [TpMe2Ir(C6H5) 2] fragment induces both aromatic and aliphatic C-H bond activation reactions, along with C-C bond formation, when heated with benzene and 1,2-dimethoxyethane.
Asymmetric epoxidation of unfunctionalized olefins catalyzed by Jacobsen's catalyst on alkoxyl-modified zirconium poly (styrene-phenylvinylphosphonate)-phosphate (ZPS-PVPA)
Huang, Jing,Luo, Yan,Cai, Jiali,Chen, Xiaohong
, p. 20 - 26 (2016/07/06)
New chiral Jacobsen's catalysts grafted onto alkoxyl-modified ZPS-PVPA are synthesized and applied in asymmetric epoxidations of unfunctionalized olefins. Specially, the supported catalysts indicate excellent catalytic activities (conv%, up to 96; sele%, up to 96; ee%, up to >99) in the absence of N-methylmorpholine N-oxide (NMO) by virtue of the special configurations of the catalysts. The superior stability (recycling for ten times) and the comfortable dispositions in large-scale reactions (such as 200 times) grant the potential application in industry to the heterogeneous catalysts.
COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES
-
Page/Page column 53-54, (2013/07/19)
The present invention provides novel phenylcycloalkylmethylamme derivatives, and methods of preparing phenylcycloalkylmethylamme derivatives. The present invention also provides methods of using phenylcycloalkylmethylamme derivatives and compositions of phenylcycloalkylmethylamme derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co- morbid indications and depression and depression related co-morbid indications.
